Samsrita Labs Limited has announced plans to invest Rs 1 crore in S Labs Hygiene Care and execute transactions worth Rs 25 crore. The company is also securing a Rs 1 crore loan from its Director. Shareholders will vote on these related-party proposals during an EGM scheduled for October 26, 2026.
Samsrita Labs Proposes Rs 26 Crore Related Party Deals and Loans
Investment of Rs 1 crore in CCPS and sales transactions worth Rs 25 crore approved.
Unsecured loan of Rs 1 crore to be provided by Non-Executive Director Ravikanth Naga Pattabhi Chopperla.
Reader Takeaway: Expansion into pet care via related parties; watch for EGM approval and governance oversight on deals.
What just happened
The Board of Directors at Samsrita Labs has greenlit three key proposals requiring shareholder consent at an upcoming EGM on October 26, 2026. The plans include an investment of up to Rs 1 crore in Compulsory Convertible Preference Shares (CCPS) of S Labs Hygiene Care Private Limited. Additionally, the company intends to conduct sales transactions with the same entity totaling Rs 25 crore. Finally, the board approved an unsecured loan facility of Rs 1 crore from Non-Executive Director Mr. Ravikanth Naga Pattabhi Chopperla.
Why this matters
The transactions mark a significant strategic pivot for Samsrita Labs as it expands its operations into the pet grooming, hygiene, and wellness sector. By establishing a commercial pipeline with S Labs Hygiene Care, the company aims to capture synergies and increase business volumes. However, as the counterparty is controlled by a common director who holds an 80% stake, these deals fall under related party transactions, necessitating public disclosure and shareholder approval.
Governance and Risks
The company has affirmed that these transactions are being conducted at arm's length. Investors should note that while these arrangements facilitate faster entry into the pet care market, they involve significant financial ties to an entity where a director has a controlling interest. Monitoring the EGM vote is critical, as governance-focused investors often scrutinize the terms and necessity of director-funded working capital loans and related party sales.
What to track next
Shareholders will meet via video conference on October 26, 2026, to vote on the proposals. Post-meeting, the effective period for these approved transactions will remain valid for one year from the date of authorization.